arm,study,column_header,obs
Milnacipran 50 - 200mg,Bateman 2011,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,25.3
Milnacipran 50 - 200mg,Bateman 2011,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_n,20
Placebo,Bateman 2011,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,14.3
Placebo,Bateman 2011,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_n,3
Placebo,Vitton 2004,pain_50_percent_reduction_in_paper_gracely_pain_scores_4_0_unit_decrease_endpoint_percent,14
Placebo,Vitton 2004,pain_50_percent_reduction_in_paper_gracely_pain_scores_4_0_unit_decrease_endpoint_n,4
Placebo,Vitton 2004,pain_50_percent_reduction_in_vas_0_10_endpoint_percent,21
Placebo,Vitton 2004,pain_50_percent_reduction_in_vas_0_10_endpoint_n,6
Milnacipran 25-200mg/day [q.d],Vitton 2004,pain_50_percent_reduction_in_paper_gracely_pain_scores_4_0_unit_decrease_endpoint_percent,28
Milnacipran 25-200mg/day [q.d],Vitton 2004,pain_50_percent_reduction_in_paper_gracely_pain_scores_4_0_unit_decrease_endpoint_n,13
Milnacipran 25-200mg/day [q.d],Vitton 2004,pain_50_percent_reduction_in_vas_0_10_endpoint_percent,26
Milnacipran 25-200mg/day [q.d],Vitton 2004,pain_50_percent_reduction_in_vas_0_10_endpoint_n,12
Milnacipran 25-200mg/day [b.i.d],Vitton 2004,pain_50_percent_reduction_in_paper_gracely_pain_scores_4_0_unit_decrease_endpoint_percent,37
Milnacipran 25-200mg/day [b.i.d],Vitton 2004,pain_50_percent_reduction_in_paper_gracely_pain_scores_4_0_unit_decrease_endpoint_n,19
Milnacipran 25-200mg/day [b.i.d],Vitton 2004,pain_50_percent_reduction_in_vas_0_10_endpoint_percent,29
Milnacipran 25-200mg/day [b.i.d],Vitton 2004,pain_50_percent_reduction_in_vas_0_10_endpoint_n,15
Placebo,Talley 2008,responders_participants_with_a_50_percent_relief_of_ibs_symptoms_endpoint_percent,56
Imipramine - 50mg,Talley 2008,responders_participants_with_a_50_percent_relief_of_ibs_symptoms_endpoint_percent,56
Citalopram - 40mg,Talley 2008,responders_participants_with_a_50_percent_relief_of_ibs_symptoms_endpoint_percent,47
Placebo,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_percent,29.2
Placebo,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_n,33
Duloxetine - 20mg,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_percent,21.43
Duloxetine - 20mg,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_n,12
Duloxetine - 60mg,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_percent,34.55
Duloxetine - 60mg,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_n,38
Duloxetine - 120mg,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_percent,36.7
Duloxetine - 120mg,Skljarevski 2009,pain_50_percent_reduction_of_weekly_mean_score_in_24_hour_average_pain_severity_ratings_locf_endpoint_n,40
Placebo,Shinichi 2016,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_endpoint_percent,39.4
Duloxetine 60mg,Shinichi 2016,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_endpoint_percent,56.5
Placebo,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_bocf_endpoint_percent,13.4
Placebo,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_bocf_endpoint_n,16
Placebo,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_locf_endpoint_percent,16.0
Placebo,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_locf_endpoint_n,19
Duloxetine 60mg,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_bocf_endpoint_percent,20.9
Duloxetine 60mg,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_bocf_endpoint_n,24
Duloxetine 60mg,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_locf_endpoint_percent,22.6
Duloxetine 60mg,Vollmer 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_locf_endpoint_n,26
Pregabalin 75-300mg,Bansal 2009,pain_improvement_in_vas_good_more_than_50_percent_percent,48
Pregabalin 75-300mg,Bansal 2009,pain_improvement_in_vas_good_more_than_50_percent_n,21
Amitriptyline 10-50 mg,Bansal 2009,pain_improvement_in_vas_good_more_than_50_percent_percent,34
Amitriptyline 10-50 mg,Bansal 2009,pain_improvement_in_vas_good_more_than_50_percent_n,15
Placebo,Allen 2017,responders_50_percent_or_greater_reduction_of_pain_from_baseline_0_10_nrs_endpoint_percent,22
Desvenlafaxine  - 50mg,Allen 2017,responders_50_percent_or_greater_reduction_of_pain_from_baseline_0_10_nrs_endpoint_percent,24
Desvenlafaxine  - 100mg,Allen 2017,responders_50_percent_or_greater_reduction_of_pain_from_baseline_0_10_nrs_endpoint_percent,22
Desvenlafaxine  - 200mg,Allen 2017,responders_50_percent_or_greater_reduction_of_pain_from_baseline_0_10_nrs_endpoint_percent,25
Desvenlafaxine  - 400mg,Allen 2017,responders_50_percent_or_greater_reduction_of_pain_from_baseline_0_10_nrs_endpoint_percent,18
Placebo,Tanum 1996,percentage_of_responders_participants_with_50_percent_improvement_in_pain_100_mm_vas_endpoint_percent,18
Placebo,Tanum 1996,percentage_of_responders_participants_with_50_percent_improvement_in_pain_100_mm_vas_endpoint_n,4
Mianserin - 120mg,Tanum 1996,percentage_of_responders_participants_with_50_percent_improvement_in_pain_100_mm_vas_endpoint_percent,76
Mianserin - 120mg,Tanum 1996,percentage_of_responders_participants_with_50_percent_improvement_in_pain_100_mm_vas_endpoint_n,19
Placebo,Wernicke 2006,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_baseline_percent,27
Duloxetine 60mg,Wernicke 2006,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_baseline_percent,43
Duloxetine 120mg,Wernicke 2006,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_baseline_percent,53
Placebo,Rowbotham 2004,pain_intensity_participants_with_reduction_of_50_percent_from_baseline_in_vas_pi_scores_endpoint_percent,34
Venlafaxine - 150-225mg,Rowbotham 2004,pain_intensity_participants_with_reduction_of_50_percent_from_baseline_in_vas_pi_scores_endpoint_percent,56
Placebo,Frakes 2011,pain_participants_with_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_bocf_percent,13.5
Placebo,Frakes 2011,pain_participants_with_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_bocf_n,35
Placebo,Frakes 2011,pain_participants_with_50_percent_decrease_in_bpi_average_pain_score_endpoint_locf_percent,21.1
Placebo,Frakes 2011,pain_participants_with_50_percent_decrease_in_bpi_average_pain_score_endpoint_locf_n,41
Duloxetine - 60-120mg,Frakes 2011,pain_participants_with_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_bocf_percent,27.7
Duloxetine - 60-120mg,Frakes 2011,pain_participants_with_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_bocf_n,73
Duloxetine - 60-120mg,Frakes 2011,pain_participants_with_50_percent_decrease_in_bpi_average_pain_score_endpoint_locf_percent,45.7
Placebo,Smith 2013,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,8.5
Placebo,Smith 2013,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_n,8
Duloxetine - 60mg,Smith 2013,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,20.7
Duloxetine - 60mg,Smith 2013,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_n,18
Nortriptyline - 25-75mg,Zakerkish 2017,pain_response_patients_with_50_percent_decrease_in_mean_weekly_pain_endpoint_percent,26.31
Duloxetine - 30-60mg,Zakerkish 2017,pain_response_patients_with_50_percent_decrease_in_mean_weekly_pain_endpoint_percent,60.65
Lamotrigine 50-200mg,Jose 2007,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_percent,41
Lamotrigine 50-200mg,Jose 2007,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_n,19
Amitriptyline 10-50mg,Jose 2007,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_percent,28
Amitriptyline 10-50mg,Jose 2007,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_n,13
Amitriptyline 10-50mg,Kaur 2011,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_percent,55
Amitriptyline 10-50mg,Kaur 2011,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_n,32
Amitriptyline 10-50mg,Kaur 2011,pain_50_percent_decrease_from_baseline_in_average_pain_score_baseline_percent,55
Duloxetine 20-60mg,Kaur 2011,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_percent,59
Duloxetine 20-60mg,Kaur 2011,improvement_reduction_in_median_pain_score_vas_50_percent_good_response_n,34
Duloxetine 20-60mg,Kaur 2011,pain_50_percent_decrease_from_baseline_in_average_pain_score_baseline_percent,59
Placebo,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_percent,6
Placebo,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_n,4
Pregabalin - 300mg,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_percent,12
Pregabalin - 300mg,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_n,8
Imipramine - 25-75mg,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_percent,20
Imipramine - 25-75mg,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_n,14
Combination,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_percent,28
Combination,Holbech 2015,good_pain_relief_50_percent_relief_endpoint_n,19
Placebo,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_3_months_acute_phase_post_intervention_percent,23.7
Placebo,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_6_months_continuation_phase_post_intervention_percent,21.6
Duloxetine - 20 then 60mg,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_3_months_acute_phase_post_intervention_percent,32.5
Duloxetine - 20 then 60mg,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_6_months_continuation_phase_post_intervention_percent,36.4
Duloxetine - 60mg,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_3_months_acute_phase_post_intervention_percent,34.0
Duloxetine - 60mg,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_6_months_continuation_phase_post_intervention_percent,32.6
Duloxetine - 120mg,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_3_months_acute_phase_post_intervention_percent,40.1
Duloxetine - 120mg,Russell 2008,participants_with_reduction_of_50_percent_in_the_bpi_modified_short_form_24_hour_average_pain_score_6_months_continuation_phase_post_intervention_percent,35.9
Placebo,Schukro 2016,pain_50_percent_reduction_in_vas_0_10_endpoint_percent,8
Placebo,Schukro 2016,pain_50_percent_reduction_in_vas_0_10_endpoint_n,2
Duloxetine ≤120mg,Schukro 2016,pain_50_percent_reduction_in_vas_0_10_endpoint_percent,40
Duloxetine ≤120mg,Schukro 2016,pain_50_percent_reduction_in_vas_0_10_endpoint_n,10
Placebo,Raskin 2005,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_endpoint_percent,30
Duloxetine 60mg (60mgQD),Raskin 2005,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_endpoint_percent,50
Placebo,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_percent,26
Placebo,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_n,29
Duloxetine 20mg,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_percent,41
Duloxetine 20mg,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_n,46
Duloxetine 60mg,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_percent,49
Duloxetine 60mg,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_n,55
Duloxetine 120mg,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_percent,52
Duloxetine 120mg,Goldstein 2005,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_n,57
Placebo,Patkar 2007,fibromyalgia_impact_50_percent_reduction_in_fiq_baseline_percent,13.7
Placebo,Patkar 2007,fibromyalgia_impact_50_percent_reduction_in_fiq_baseline_n,8
Paroxetine CR (12.5-62.5mg),Patkar 2007,fibromyalgia_impact_50_percent_reduction_in_fiq_baseline_percent,25.8
Paroxetine CR (12.5-62.5mg),Patkar 2007,fibromyalgia_impact_50_percent_reduction_in_fiq_baseline_n,15
Venlafaxine 37.5 mg,Tasmuth 2002,pain_50_percent_decrease_from_baseline_typical_pain_intensity_post_intervention_grouped_for_venlafaxine_altogether_not_by_dose_percent,84.6
Venlafaxine 37.5 mg,Tasmuth 2002,pain_50_percent_decrease_from_baseline_typical_pain_intensity_post_intervention_grouped_for_venlafaxine_altogether_not_by_dose_n,2
Placebo,Mease 2009,pain_relief_50_percent_relief_of_ped_24_hr_morning_recall_scores_completers_only_15_weeks_within_trial_percent,26.2
Milnacipran 100mg,Mease 2009,pain_relief_50_percent_relief_of_ped_24_hr_morning_recall_scores_completers_only_15_weeks_within_trial_percent,34.7
Milnacipran 200mg,Mease 2009,pain_relief_50_percent_relief_of_ped_24_hr_morning_recall_scores_completers_only_15_weeks_within_trial_percent,37
Carbamazepine 400mg/day,Razazian 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,41.2
Carbamazepine 400mg/day,Razazian 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_n,35
Pregabalin 150mg/day,Razazian 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,76.7
Pregabalin 150mg/day,Razazian 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_n,66
Venlafaxine 150mg/day,Razazian 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,41.9
Venlafaxine 150mg/day,Razazian 2014,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_n,36
Morphine,Gilron 2015,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,25.6
Nortriptyline,Gilron 2015,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,36.8
Nortriptyline + Morphine,Gilron 2015,pain_50_percent_decrease_from_baseline_in_average_pain_score_endpoint_percent,52.6
Placebo,Gao 2010,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_percent,50.50
Placebo,Gao 2010,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_n,55
Duloxetine - 60-120mg,Gao 2010,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_percent,54.80
Duloxetine - 60-120mg,Gao 2010,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_n,57
Placebo,Skljarevski 2010 | 1,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_percent,27.0
Placebo,Skljarevski 2010 | 1,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_n,31
Placebo,Skljarevski 2010 | 1,participants_with_a_50_percent_reduction_in_the_weekly_mean_of_the_24_hour_average_pain_score_diary_based_endpoint_percent,19.0
Duloxetine - 60-120mg,Skljarevski 2010 | 1,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_percent,38.5
Duloxetine - 60-120mg,Skljarevski 2010 | 1,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_n,42
Duloxetine - 60-120mg,Skljarevski 2010 | 1,participants_with_a_50_percent_reduction_in_the_weekly_mean_of_the_24_hour_average_pain_score_diary_based_endpoint_percent,31.5
Placebo,Yasuda 2011,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_percent,19.8
Placebo,Yasuda 2011,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_n,33
Duloxetine - 40mg,Yasuda 2011,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_percent,37.6
Duloxetine - 40mg,Yasuda 2011,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_n,32
Duloxetine - 60mg,Yasuda 2011,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_percent,40.7
Duloxetine - 60mg,Yasuda 2011,pain_participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_endpoint_n,35
Placebo,Skljarevski 2010 | 2,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_baseline_percent,34.7
Placebo,Skljarevski 2010 | 2,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_baseline_n,69
Duloxetine 60mg,Skljarevski 2010 | 2,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_baseline_percent,48.7
Duloxetine 60mg,Skljarevski 2010 | 2,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_baseline_n,95
Placebo,Wang 2017,participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_post_intervention_percent,34.5
Placebo,Wang 2017,participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_post_intervention_n,68
Duloxetine - 60mg,Wang 2017,participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_post_intervention_percent,42.8
Duloxetine - 60mg,Wang 2017,participants_with_reduction_of_50_percent_in_the_bpi_24_hour_average_pain_score_post_intervention_n,83
Placebo + Gabapentin - 2400mg,Lipone 2020,pain_participants_with_a_50_percent_reduction_in_24_h_average_pain_bpi_sf_item_5_post_intervention_percent,45.8
Placebo + Gabapentin - 2400mg,Lipone 2020,pain_participants_with_a_50_percent_reduction_in_24_h_average_pain_bpi_sf_item_5_post_intervention_n,22
Trazodone - 30mg + Gabapentin - 2400mg,Lipone 2020,pain_participants_with_a_50_percent_reduction_in_24_h_average_pain_bpi_sf_item_5_post_intervention_percent,62.8
Trazodone - 30mg + Gabapentin - 2400mg,Lipone 2020,pain_participants_with_a_50_percent_reduction_in_24_h_average_pain_bpi_sf_item_5_post_intervention_n,27
Trazodone - 60mg + Gabapentin - 2400mg,Lipone 2020,pain_participants_with_a_50_percent_reduction_in_24_h_average_pain_bpi_sf_item_5_post_intervention_percent,54
Trazodone - 60mg + Gabapentin - 2400mg,Lipone 2020,pain_participants_with_a_50_percent_reduction_in_24_h_average_pain_bpi_sf_item_5_post_intervention_n,27
Placebo,Gao 2015,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_percent,28.8
Placebo,Gao 2015,pain_50_percent_decrease_in_average_pain_severity_in_bpi_endpoint_percent,29.4
Duloxetine 60mg,Gao 2015,pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_percent,42.0
Duloxetine 60mg,Gao 2015,pain_50_percent_decrease_in_average_pain_severity_in_bpi_endpoint_percent,46.0
Placebo,Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_n,71
Placebo,Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_percent,38
Placebo,Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_confidence_limits,27-50
Placebo,Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_n,66
Placebo,Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_percent,38
Placebo,Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_confidence_limits,27-50
Clomipramine (75-150mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_n,56
Clomipramine (75-150mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_percent,50
Clomipramine (75-150mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_confidence_limits,36-64
Clomipramine (75-150mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_n,62
Clomipramine (75-150mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_percent,48
Clomipramine (75-150mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_confidence_limits,31-61
Mianserin (30-60mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_n,53
Mianserin (30-60mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_percent,57
Mianserin (30-60mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_completers_post_intervention_confidence_limits,33-61
Mianserin (30-60mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_n,64
Mianserin (30-60mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_percent,45
Mianserin (30-60mg),Loldrup 1989,pain_50_percent_decrease_from_baseline_vas_pain_score_endpoint_post_intervention_confidence_limits,33-58
Pregabalin,Tesfaye 2013,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_endpoint_percent,27.8
Pregabalin,Tesfaye 2013,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_endpoint_n,104
Duloxetine 60mg,Tesfaye 2013,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_endpoint_percent,40.3
Duloxetine 60mg,Tesfaye 2013,pain_50_percent_decrease_in_bpi_24_hour_average_pain_score_endpoint_n,151
Placebo,Uchio 2018,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_post_intervention_percent,38.6
Placebo,Uchio 2018,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_post_intervention_n,68
Placebo,Uchio 2018,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_post_intervention_percent,39.2
Placebo,Uchio 2018,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_post_intervention_n,69
Duloxetine 60mg,Uchio 2018,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_post_intervention_percent,55.4
Duloxetine 60mg,Uchio 2018,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_post_intervention_n,98
Duloxetine 60mg,Uchio 2018,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_post_intervention_percent,64.4
Duloxetine 60mg,Uchio 2018,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_post_intervention_n,114
Pregabalin - 300–600 mg,Nct 2015,participants_with_a_50_percent_reduction_in_the_weekly_mean_of_the_24_hour_average_pain_score_on_the_11_point_nrs_endpoint_percent,41.6
Pregabalin - 300–600 mg,Nct 2015,participants_with_a_50_percent_reduction_in_the_weekly_mean_of_the_24_hour_average_pain_score_on_the_11_point_nrs_endpoint_n,62
Duloxetine - 40–60 mg,Nct 2015,participants_with_a_50_percent_reduction_in_the_weekly_mean_of_the_24_hour_average_pain_score_on_the_11_point_nrs_endpoint_percent,40.8
Duloxetine - 40–60 mg,Nct 2015,participants_with_a_50_percent_reduction_in_the_weekly_mean_of_the_24_hour_average_pain_score_on_the_11_point_nrs_endpoint_n,62
Placebo,Chappell 2011,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_endpoint_percent,22.2
Placebo,Chappell 2011,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,32.3
Duloxetine (60-120mg),Chappell 2011,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_endpoint_percent,37.9
Duloxetine (60-120mg),Chappell 2011,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,43.8
Placebo,Chappell 2009 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_percent,29.4
Duloxetine 60-120mg,Chappell 2009 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_percent,47.2
Placebo,Arnold 2012 | 1,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,35.9
Duloxetine - 30mg,Arnold 2012 | 1,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,36.6
Placebo,Arnold 2005,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,23
Placebo,Arnold 2005,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_n,27
Duloxetine - 60mg,Arnold 2005,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,41
Duloxetine - 60mg,Arnold 2005,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_n,48
Duloxetine - 120mg,Arnold 2005,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_percent,41
Duloxetine - 120mg,Arnold 2005,pain_bpi_average_pain_severity_score_50_percent_decrease_from_baseline_to_endpoint_endpoint_n,47
Placebo,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_percent,12.0
Placebo,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_n,33
Esreboxetine - 4mg,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_percent,17.9
Esreboxetine - 4mg,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_n,49
Esreboxetine - 8mg,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_percent,20.1
Esreboxetine - 8mg,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_n,56
Esreboxetine - 10mg,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_percent,15.0
Esreboxetine - 10mg,Arnold 2012 | 2,pain_50_percent_decrease_from_baseline_in_mean_pain_score_endpoint_n,42
Placebo,Arnold 2010 | 1,pain_ped_24_hour_recall_pain_score_50_percent_improvement_from_baseline_endpoint_percent,18.1
Placebo,Arnold 2010 | 1,pain_ped_24_hour_recall_pain_score_50_percent_improvement_from_baseline_endpoint_n,92
Milnacipran - 100mg,Arnold 2010 | 1,pain_ped_24_hour_recall_pain_score_50_percent_improvement_from_baseline_endpoint_percent,27.7
Milnacipran - 100mg,Arnold 2010 | 1,pain_ped_24_hour_recall_pain_score_50_percent_improvement_from_baseline_endpoint_n,143
Placebo,Allen 2014,pain_50_percent_or_greater_reduction_from_baseline_in_nrs_pain_score_responders_endpoint_percent,26
Desvenlafaxine - 50mg,Allen 2014,pain_50_percent_or_greater_reduction_from_baseline_in_nrs_pain_score_responders_endpoint_percent,35
Desvenlafaxine - 100mg,Allen 2014,pain_50_percent_or_greater_reduction_from_baseline_in_nrs_pain_score_responders_endpoint_percent,37
Desvenlafaxine - 200mg,Allen 2014,pain_50_percent_or_greater_reduction_from_baseline_in_nrs_pain_score_responders_endpoint_percent,36
Desvenlafaxine - 400mg,Allen 2014,pain_50_percent_or_greater_reduction_from_baseline_in_nrs_pain_score_responders_endpoint_percent,32
Placebo,Arnold 2010 | 2,number_of_responders_50_percent_improvement_in_brief_pain_inventory_average_pain_bocf_endpoint_percent,16.5
Duloxetine - 60-120mg,Arnold 2010 | 2,number_of_responders_50_percent_improvement_in_brief_pain_inventory_average_pain_bocf_endpoint_percent,24.7
Placebo,Arnold 2010 | 3,pain_response_patients_with_50_percent_decrease_in_mean_weekly_pain_endpoint_percent,8.3
Placebo,Arnold 2010 | 3,pain_response_patients_with_50_percent_decrease_in_mean_weekly_pain_endpoint_n,11
Esreboxetine - 8mg,Arnold 2010 | 3,pain_response_patients_with_50_percent_decrease_in_mean_weekly_pain_endpoint_percent,18.0
Esreboxetine - 8mg,Arnold 2010 | 3,pain_response_patients_with_50_percent_decrease_in_mean_weekly_pain_endpoint_n,24
Placebo,Miki 2016,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_baseline_percent,15.6
Placebo,Miki 2016,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_baseline_n,33
Mirtazapine 30mg,Miki 2016,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_baseline_percent,19.4
Mirtazapine 30mg,Miki 2016,pain_50_percent_decrease_in_weekly_mean_24_hour_pain_severity_baseline_n,41
